| Literature DB >> 29151978 |
Jiewei Chen1,2, Pengfei Yang3, Yongbo Xiao1, Yijun Zhang1, Jun Liu1, Dan Xie1,2, Muyan Cai1,2, Xinke Zhang1,2.
Abstract
Purpose: The aim of this study is to investigate the differential expression of α-sma-positive fibroblasts (CAFs) in nasopharyngeal carcinomas (NPCs), nasopharyngitis, metastatic tissues of NPCs and its prognostic value in NPCs.Entities:
Keywords: CAFs; Nasopharyngeal Carcinomas; Prognosis; α-sma
Year: 2017 PMID: 29151978 PMCID: PMC5688944 DOI: 10.7150/jca.20324
Source DB: PubMed Journal: J Cancer ISSN: 1837-9664 Impact factor: 4.207
Figure 1The expression of α-sma in nasopharyngeal tissues (A, E) is the expression of α-sma in nasopharyngeal carcinoma tissues (CAFs high density), (B, F) (CAFs low density); (C, G) is the expression in nasopharyngeal tissues (CAFs low density); (D, H) is the expression in the metastatic tissues of nasopharyngeal carcinoma (CAFs high density)
The expression of α-sma in the NPCs, Nasopharyngitis and Metastatic tissues of NPCs
| Variable | CAFs | |||
|---|---|---|---|---|
| All cases | Low density | High density | ||
| Tissue type | ||||
| NPCs | 85 | 50 (58.8%) | 35(41.2%) | |
| Nasopharyngitis | 32 | 30 (93.8%) | 2 (6.2%) | |
| Metastatic tissues of NPCs | 12 | 2 (16.7%) | 10 (83.3%) | |
a Chi-square test.
Correlation of CAFs with patients' clinicopathological features in nasopharyngeal carcinomas
| Variable | CAFs | |||
|---|---|---|---|---|
| All cases | Low density | High density | ||
| Age (years) b | 0.054 | |||
| ≤ 45.4 | 47 | 32 (68.1%) | 15 (31.9%) | |
| > 45.4 | 38 | 18 (47.4%) | 20 (52.6%) | |
| Gender | 0.521 | |||
| Male | 65 | 37 (56.9%) | 28 (43.1%) | |
| Female | 20 | 13 (65.0%) | 7 (35.0%) | |
| T stage | ||||
| T1 And T2 | 32 | 25 (78.1%) | 7 (21.9%) | |
| T3 And T4 | 53 | 25 (47.2%) | 28 (52.8%) | |
| Lymph node | 0.270 | |||
| N0 | 17 | 12 (70.6%) | 5 (29.4%) | |
| N1,N2 And N3 | 68 | 38 (55.9%) | 30 (44.1%) | |
| Therapy c | 0.793 | |||
| Therapy1 And Therapy2 | 62 | 37 (59.7%) | 25 (40.3%) | |
| Therapy3 And Therapy4 | 23 | 13 (56.5%) | 10 (43.5%) | |
| Relapse | ||||
| Yes | 11 | 3 (27.3%) | 8 (72.7%) | |
| No | 74 | 47 (63.5%) | 27 (36.5%) | |
aChi-square test, bMean age, cTherapy: Therapy 1 is Radiotherapy; Therapy 2 is Chemoradiotherapy; Therapy 3 is Inductive treatment and Radiotherapy; Therapy 4 is Inductive treatment and chemoradiotherapy.
Univariate analysis of clinicopathologic variables in 85 patients with nasopharyngeal carcinomas (log-rank test)
| Variable | All cases | Mean survival(months) | Median survival(months) | |
|---|---|---|---|---|
| Age (years) a | ||||
| ≤ 45.4 | 47 | 122.0 | N | |
| > 45.4 | 38 | 101.4 | ||
| Gender | 0.371 | |||
| Male | 65 | 112.1 | N | |
| Female | 20 | 118.0 | ||
| T stage | ||||
| T1 And T2 | 32 | 128.6 | N | |
| T3 And T4 | 53 | 103.3 | 121.0 | |
| Lymph node | 0.217 | |||
| N0 | 17 | 125.5 | N | |
| N1,N2 And N3 | 68 | 110.5 | ||
| Therapy b | 0.475 | |||
| Therapy1 And Therapy2 | 62 | 111.4 | N | |
| Therapy3 And Therapy4 | 23 | 119.4 | ||
| Relapse | ||||
| Yes | 11 | 78.7 | 67.0 | |
| No | 74 | 119.0 | N | |
| CAFs | 50 | 127.0 | N |
a Mean age; b Therapy: Therapy 1 is Radiotherapy; Therapy 2 is Chemoradiotherapy; Therapy 3 is Inductive treatment and Radiotherapy; Therapy 4 is Inductive treatment and Chemoradiotherapy.
COX multivariate analysis of prognostic factors on overall survival
| Variable | Hazards ratio | 95% CI | |
|---|---|---|---|
| Age (years) a (<=45.4 vs. >45.4) | 2.083 | 0.861-5.043 | 0.104 |
| T stage (T1-T2 vs. T3-T4) | 4.656 | 1.276-16.991 | |
| Relapse (No vs. Yes) | 4.760 | 1.698-13.342 | |
| CAFs density (Low vs. High) | 3.108 | 1.104-8.753 |
a Mean age.
Figure 2CAFs Kaplan-Meier survival analysis curves (A) overall survival (B) progression-free survival.